Biovie (BIVI) Non Operating Interest Expenses (2013 - 2026)

Biovie has disclosed Non Operating Interest Expenses across 12 years of filings, most recently posting $3978.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 20.41% year-over-year to $3978.0; the TTM figure through Jun 2026 stood at $17901.0 (down 94.62% YoY), while the FY2026 annual figure was $17901.0, down 94.62% from the prior year.
• Non Operating Interest Expenses came in at $3978.0 for Q2 2026 at Biovie, down from $5967.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $1.1 million in Q2 2023 to a low of $1989.0 in Q3 2025.
• Average Non Operating Interest Expenses over 5 years is $529315.7, with a median of $534327.0 recorded in 2024.
• Year-over-year, Non Operating Interest Expenses jumped 98643.27% in 2022 and plunged 99.22% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $1.1 million in 2022, then retreated by 25.4% to $820600.0 in 2023, then slumped by 91.87% to $66700.0 in 2024, then plunged by 91.05% to $5967.0 in 2025, then slumped by 33.33% to $3978.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $3978.0 in Q2 2026, $5967.0 in Q1 2026, and $5967.0 in Q4 2025.